Signal Podcast

By  Luke Timmerman and Meg Tirrell

A podcast that explores how your medicines get made. Subscribe to Signal on iTunes or Stitcher or Google Play. Get an alert when each new episode drops by clicking here.

Signal: P Value
Signal Podcast

LISTEN: One humble test that makes or breaks companies and careers

By Luke Timmerman and Meg Tirrell

Signal: Golden Ticket Funding
Signal Podcast

Episode 20: The death of a child and a golden ticket for drug makers

By Luke Timmerman and Meg Tirrell

Signal Podcast

Episode 19: From poop transplants to pill politics, here’s the year in ‘Signal’

By Luke Timmerman and Meg Tirrell

Signal: Episode
Signal Podcast

Episode 18: How our next president could affect drug prices

By Meg Tirrell and Luke Timmerman

Signal: Gene Drive
Signal Podcast

Episode 17: Gene-editing might eradicate disease — or be Pandora’s box in a bottle

By Meg Tirrell and Luke Timmerman

Signal Podcast: Patent monopolies
Signal Podcast

Episode 16: To make big profits, drug companies turn to monopoly shenanigans

By Luke Timmerman and Meg Tirrell

Signal: Race for vaccine
Signal Podcast

Episode 15: Can scientists keep pace with Zika to develop a vaccine?

By Meg Tirrell and Luke Timmerman

Signal: Hamster delivery
Signal Podcast

Episode 14: The Chinese hamsters that helped birth biotech

By Luke Timmerman and Meg Tirrell

Signal Episode 13: Microbe Army
Signal Podcast

Episode 13: The superbugs are winning the battle against us

By Meg Tirrell and Luke Timmerman

Podcast - Mystery Pill
Signal Podcast

Episode 12: Before you pop that Tylenol, tune into this podcast

By Luke Timmerman and Meg Tirrell

Podcast: BioTech Sexism
Signal Podcast

Episode 11: Sexism in biotech, from scantily clad models to how gender affects this podcast

By Meg Tirrell and Luke Timmerman

Signal: Cancer is a dirty ninja gangster rat
Signal Podcast

Episode 10: Cancer is a low-down, dirty gangster ninja

By Luke Timmerman and Meg Tirrell

Signal: Shark vs Snail
Signal Podcast

Episode 9: How our perceptions of risk — and killer snails! — affect our health

By Meg Tirrell and Luke Timmerman

Signal: Stock Market Medicine
Signal Podcast

Episode 8: How Wall Street reacts when a patient dies in a clinical trial

By Meg Tirrell and Luke Timmerman

Signal - Cost For Cures
Signal Podcast

Episode 7: How much are we willing to pay for cures?

By Luke Timmerman and Meg Tirrell

Alzheimer's debate
Signal Podcast

Episode 6: Choosing scientific sides in the fight against Alzheimer’s

By Meg Tirrell and Luke Timmerman

Signal Episode 5: J.P. Morgan Healthcare Conference
Signal Podcast

Episode 5: How biotech went from a risky investment to a booming business

By Luke Timmerman and Meg Tirrell

Genome Sequencing
Signal Podcast

Episode 4: A shoppers guide to the genome sequencing market

By Meg Tirrell and Luke Timmerman

Signal Podcast

Episode 3: Should we believe published scientific research?

By Luke Timmerman and Meg Tirrell

Signal Podcast

Episode 2: For boys with Duchenne, and two drug companies, a moment of shared hope

By Meg Tirrell and Luke Timmerman

Signal Podcast

Episode 1: We are a constellation of our microbiome and ourselves

By Meg Tirrell and Luke Timmerman

Signal Podcast

Hello, world! It’s Signal.

By Luke Timmerman and Meg Tirrell

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy